Profile
Sector:
HealthcareIndustry:
BiotechnologyCountry:
United StatesIPO:
23 May 2008Website:
http://www.cervomed.comNext earnings report:
15 August 2024Last dividends:
N/ANext dividends:
N/APrice
regular market | Thu, 20 Jun 2024 13:30:00 GMTDividend
Analysts recommendations
Institutional Ownership
CRVO Latest News
Results from the phase 2b RewinD-LB study, using neflamapimod for the treatment of patients with Dementia With Lewy bodies, are expected in the 2nd half of 2024. The global Lewy body Dementia treatment market is projected to reach $8.45 billion by 2033. If targeting of p38 alpha protein to inhibit synaptic dysfunction works for DLB, then potential to apply the same mechanism of action towards Alzheimer's Disease, Frontotemporal dementia, and other neurological disorders.
BOSTON, March 28, 2024 (GLOBE NEWSWIRE) -- CervoMed Inc. (NASDAQ: CRVO), a clinical stage company focused on developing treatments for age-related neurologic disorders, today announced that Company's Management will participate in the following three investor conferences during the month of April:
What type of business is CervoMed?
CervoMed Inc., a clinical-stage biotechnology company, engages in the development and commercialization of drug treatments for neurodegenerative diseases. It develops neflamapimod, an orally administered small molecule brain penetrant for the treatment of dementia with Lewy bodies (DLB), Alzheimer's diseases, and brain stroke recovery. The company is based in Boston, Massachusetts.
What sector is CervoMed in?
CervoMed is in the Healthcare sector
What industry is CervoMed in?
CervoMed is in the Biotechnology industry
What country is CervoMed from?
CervoMed is headquartered in United States
When did CervoMed go public?
CervoMed initial public offering (IPO) was on 23 May 2008
What is CervoMed website?
https://www.cervomed.com
Is CervoMed in the S&P 500?
No, CervoMed is not included in the S&P 500 index
Is CervoMed in the NASDAQ 100?
No, CervoMed is not included in the NASDAQ 100 index
Is CervoMed in the Dow Jones?
No, CervoMed is not included in the Dow Jones index
When does CervoMed report earnings?
The next expected earnings date for CervoMed is 15 August 2024